baber/WOPTO huggingface dataset:
Patent DE-69200262-D1 (DE)
Inventor: MAZERAN JEAN-JACQUES
IPC: B22C9/03
Filed: 1992-01-20
Granted: 1994-09-01
Abstract: The invention concerns a device and method for continuous fabricating of foundry molds from granular material. The device consists of a frame (10) with lights (11) supporting through swivels (31) caissons (30, 40) with large partitions (42) provided with grooves (421) into which pattern-plates (60) are inserted, and with small partitions (43) provided with suction holes (431); the caissons being connected to a vacuum source through flexible hoses controlled by solenoid valves; the whole assembly being placed after heat-forming of a polymer film (92) around a grid (70) with a hollow rib (74) and filter (741) connected to a vacuum source through a connector (75).
Patent DE-69200587-D1 (DE)
Inventor: ERIKSEN SVEND
IPC: C12P21/06
Filed: 1992-01-10
Granted: 1994-12-01
Abstract: The method for production of a vegetable protein hydrolyzate comprises a combination of i.a. an ultrafiltration and a non-pH-stat hydrolysis of a vegetable protein. Hereby a protein hydrolyzate is generated, which exhibits satisfactory organoleptic properties and which can be produced in high yield.
Patent DE-69204474-D1 (DE)
Inventor: PEGLION JEAN-LOUIS
IPC: A61P25/04
Filed: 1992-01-08
Granted: 1995-10-12
Abstract: New benzisoxazole and benzisothiazole derivatives usable as medication and corresponding to the formula: 
<IMAGE>
 in which: 
 
  - each of X1, X2, X3, X4 and X5, which are identical or different, is: hydrogen, halogen, [(C1-C5)-alkyl, -alkoxy or -alkylthio], hydroxyl, acyloxy, trifluoromethyl, nitro, amino or acetamido, or 
  - two of them, in adjacent position, together form a methylenedioxy, ethylenedioxy or vinylenedioxy radical; 
  - R1 is hydrogen or C1-C5 alkyl; 
  - each of m and n denotes zero, one, two or three on condition that m + n is >/= 1; 
  - p is zero or an integer from 1 to 6; 
  - q is two or three and 
  - Y is oxygen or S(O)z, z being zero, one or two;
 in racemic and optically active form. 
 
<??>These derivatives and their physiologically tolerable salts can be employed in therapeutics as sedative, anxiolytic, antiaggressive and analgesic agents and for the treatment of schizophrenia and of depression.
Patent DE-69208434-D1 (DE)
Inventor: USUI SATOSHI
IPC: C08J5/12
Filed: 1992-12-11
Granted: 1996-03-28
Abstract: A pair of tubular products (1a,1b) of polyarylene sulfide having end faces to be welded are welded to each other by heating the end faces by a hot plate (7) in no contact with the end faces to a surface temperature which is at least the melting heat-absorption peak temperature and at most 80  DEG C above the melting initiation temperature of the polyarylene sulfide, and abutting the end faces under a pressure of 50 - 1500 kPa when the end faces are at a surface temperature which is at least 10  DEG C above the melting initiation temperature and not exceeding the melting heat-absorption peak temperature of the polyarylene sulfide. As a result, a welded tubular structure having a weld with a small inside bead (9) but having a sufficiently large weld strength can be obtained with substantially no thermal degradation and at a good operating efficiency. <IMAGE>
Patent DE-69215666-D1 (DE)
Inventor: DRAPER STEPHEN ROBERT
IPC: G09B15/00
Filed: 1992-03-31
Granted: 1997-01-16
Abstract: PCT No. PCT/GB92/00573 Sec. 371 Date Feb. 1, 1994 Sec. 102(e) Date Feb. 1, 1994 PCT Filed Mar. 31, 1992 PCT Pub. No. WO92/17868 PCT Pub. Date Oct. 15, 1992A learning aid adapted to be attached to an instrument of the type defined. The learning aid is arranged to lie generally parallel with the fretboard or fingerboard of the instrument and to afford a visual display indicating the string or strings, and the position at which the string or strings are to be depressed against the fretboard or fingerboard to obtain a desired musical note, chord or scale.
Patent DE-69227512-D1 (DE)
Inventor: GRIFFITH OWEN
IPC: C07C281/16
Filed: 1992-03-13
Granted: 1998-12-10
Abstract: Physiologically active N6-(hydrazinoiminomethyl)lysine or pharmaceutically acceptable acid addition salt thereof is administered in a nitric oxide sythesis inhibiting amount to a subject in need of such inhibition (e.g., a subject with low blood pressure, e.g., due to sepsis or to therapeutic administration of cytokines, or needing immunosuppressive effect) or is added to a medium containing isolated organs, intact cells, cell homogenates or tissue homogenates in an amount sufficient to inhibit nitric oxide formation to elucide or control the biosynthesis, metabolism or physiological role of nitric oxide. Compared to known nitric oxide synthesis inhibitors, N6-(hydrazinoiminomethyl)lysine and its acid addition salts show a greater relative activity toward inducible isoform of nitric oxide synthase than toward constitutive isoform of nitric oxide synthase. N6-(hydrazinoiminomethyl)lysine and its pharmaceutically acceptable acid addition salts are substantially less toxic than are NG-amionoarginine and its pharmaceutically acceptable acid addition salts.
Patent DE-69305313-D1 (DE)
Inventor: MICHAEL J GABRIEL
IPC: A61K47/26
Filed: 1993-01-04
Granted: 1996-11-14
Abstract: An orally administrable therapeutic protein is provided by combining the therapeutic protein with a stabilizing agent in an aqueous solution. The solution is coated onto nonpareils and microencapsulated with a water emulsifiable enteric coating composition. The microcapsules are orally administered. The coating protects the protein as it passes through the stomach. Upon reaching the small intestines, the basic pH of the intestinal juices will dissolve the coating, allowing the protein to be released and induce antigen specific immune response which has the specificity of the native molecule. The stabilizing agent protects the therapeutic protein from denaturation during the encapsulation process. In addition to being immunogenic, when administered orally, encapsulated allergen has a therapeutic effect in the treatment of human allergies.
Patent DE-69312597-D1 (DE)
Inventor: REUTHER JAMES
IPC: F23D14/48
Filed: 1993-02-16
Granted: 1997-09-04
Abstract: A nested fiber gas burner is formed with a burner body having an inlet on one end and a burner port on the other end. A mat of fibers is formed from discrete fibers of material randomly deposited into a mold having the general configuration of the burner port. After the fibers are deposited in the mold to a depth of about 0.5 inch, they are heated to a temperature of about 1200 DEG  C. for about two hours, which causes the fibers to bond together. Thus bonded, the fiber mat is secured in place in the burner port.
Patent DE-69333019-D1 (DE)
Inventor: EVANS J
IPC: C12P21/08
Filed: 1993-08-13
Granted: 2003-07-10
Abstract: Genes encoding opioid receptors can be retrieved from vertebrate libraries using the murine probe disclosed herein under low-stringency conditions. The DNA sequence shown in Figure 5 or its complement can be used to obtain the human delta, kappa and mu genes as well as the murine mu gene. The probe provided encodes the murine delta opioid receptor.
Patent DE-69413978-D1 (DE)
Inventor: YAMASHITA RYO
IPC: A01N25/00
Filed: 1994-06-08
Granted: 1998-11-19
Abstract: PCT No. PCT/IB94/00148 Sec. 371 Date Dec. 14, 1995 Sec. 102(e) Date Dec. 14, 1995 PCT Filed Jun. 8, 1994 PCT Pub. No. WO94/29104 PCT Pub. Date Dec. 22, 1994A packaging container for chemicals such as pesticides and the like and a laminated film for forming said container, wherein the inner layer of the laminated film is constituted of an inner bag made of a water-soluble polymer film and the outer layer of the laminated film is constituted of an outer bag made of a water-insoluble film, and at least in the seal part of the container, films constituting inner layer are bonded to each other and additionally the film constituting inner layer and the film constituting outer layer are bonded to each other, and the film constituting inner layer and the film constituting outer layer are releasable from each other.
Patent DE-69414046-D1 (DE)
Inventor: HEAFIELD JOANNE
IPC: A61K31/135
Filed: 1994-06-09
Granted: 1998-11-26
Abstract: In order to provide a sustained release pharmaceutical formulation containing morphine which is suitable for administration on a once daily basis, in a first aspect, an orally administrable sustained release dosage unit form contains morphine, or a pharmaceutically acceptable salt thereof, as active ingredient, which formulation gives a peak plasma level at 1.0 to 6 hours after administration. In a second aspect, the formulation contains an effective amount of morphine or a pharmaceutically acceptable salt thereof, characterised by a W50 for the M-6-G metabolite or for morphine of between 4 and 12 hours. In a third aspect, the pharmaceutical dosage unit form is obtainable by compressing multiparticulates comprising a pharmaceutically active substance in a matrix of hydrophobic fusible material having a melting point of from 35 to 150 DEG C, the dosage form optionally containing conventional tabletting excipients. In a further aspect of the invention, sustained release multiparticulates containing morphine or a pharmaceutically acceptable salt thereof are produced by mechanically working in a high-speed mixer a mixture of particulate morphine or a pharmaceutically acceptable salt thereof and a particulate, hydrophobic fusible carrier or diluent having a melting point from 35 to 150 DEG C and optionally a release control component comprising a water soluble fusible material or a particulate soluble or insoluble organic or inorganic material at a speed and energy input which allows the carrier or diluent to melt or soften whereby it agglomerates, and breaking down the agglomerates to give controlled release particles.
Patent DE-69417445-D1 (DE)
Inventor: LEONHARD FRANK ULDALL
IPC: G10L25/51
Filed: 1994-04-22
Granted: 1999-04-29
Abstract: PCT No. PCT/DK94/00164 Sec. 371 Date Dec. 12, 1995 Sec. 102(e) Date Dec. 12, 1995 PCT Filed Apr. 22, 1994 PCT Pub. No. WO94/25958 PCT Pub. Date Nov. 10, 1994The shape of energy changes of an auditory signal is used for identifying or representing features which can be perceived by a human ear as representing a distinct sound picture. In order to extract information from the shape of the energy changes, the shape is preferably represented by the shape of a transient pulse of the signal with a rise time of at most 2 ms. It is preferred that an envelope detection is being used in order to obtain the transient signal pulse. The energy change representing the distinct sound picture can be a phoneme or vowel. The invention also relates to a method for identifying the energy changes in the auditory signal by comparing the shape of energy changes of the signal, which can be represented as the shape of the transient pulse, with predetermined energy change shapes representing distinct sound pictures. The invention also relates to a method of speech synthesis wherein a series of transient pulses is generated corresponding to the series of phonemes to be synthesized. The invention further relates to a system for processing an auditory signal in order to reduce the bandwidth of the signal with substantial retention of the information of the signal, the system comprising means for extracting the transient component of the auditory signal, and means for detecting an envelope the transient component.
Patent DE-69432300-D1 (DE)
Inventor: JUERGENSEN DR
IPC: A61L15/32
Filed: 1994-06-03
Granted: 2003-04-24
Abstract: A formulated biological adhesive composition utilizes tissue transglutaminase in a pharmaceutically acceptable aqueous carrier. The tissue transglutaminase is used in an effective catalytic amount to promote adhesion between tissue surfaces upon treatment thereof by catalyzing the reaction between glutaminyl residues and amine donors of the tissue and/or the enzyme. The carrier contains a divalent metal ion such as calcium to promote said reaction.
Patent DE-69507612-D1 (DE)
Inventor: SAILLANT YVES
IPC: B61B13/12
Filed: 1995-04-27
Granted: 1999-03-11
Abstract: PCT No. PCT/FR95/00554 Sec. 371 Date Jan. 21, 1997 Sec. 102(e) Date Jan. 21, 1997 PCT Filed Apr. 27, 1995 PCT Pub. No. WO95/29834 PCT Pub. Date Nov. 9, 1995A transport system for passive vehicles which move by way of wheels on treadways of a track includes guide surfaces for guiding the vehicles along the track. Each vehicle includes at least one drive roller propelling the vehicle through contact with rotary tubes. An axis of the drive roller is steerable with respect to the axis of the tubes. The vehicle also includes guide rollers adapted to cooperate with guide surfaces of the track. The track includes a trench containing the rotary tubes and a cover disposed atop the trench and having a lengthwise slit.
Patent DE-69508278-D1 (DE)
Inventor: BEST STEVEN
IPC: C08L23/04
Filed: 1995-12-12
Granted: 1999-04-15
Abstract: Articles fabricated from certain high molecular weight high density polyethylenes (HMW-HDPE) combined with a second component, exhibit superior puncture propagation tear resistance and puncture propagation tear length. The second component may be an elastomer such as styrene-butadiene-styrene, styrene-isoprene-styrene, EPR, EPDM, butyl rubber, metallocene-catalyzed polyethylene, and combinations thereof. The second component or components will be present in a fabricated article from 1 to 15 weight percent. Articles include films, bags made from films, and extrusion blow-molded articles.
Patent DE-69514781-D1 (DE)
Inventor: SAERKKAE VELI-MATTI
IPC: H01P7/10
Filed: 1995-10-04
Granted: 2000-03-02
Abstract: PCT No. PCT/FI95/00547 Sec. 371 Date Jun. 4, 1996 Sec. 102(e) Date Jun. 4, 1996 PCT Filed Oct. 4, 1995 PCT Pub. No. WO96/11511 PCT Pub. Date Apr. 18, 1996A dielectric resonator including a dielectric resonator body and a frequency controller for adjusting the resonance frequency by moving a conductive metal plane in the vicinity of the dielectric resonator body. The frequency controller has a cylindrical supporting block connected to a casing, and a second cylindrical supporting block gliding telescopically inside it by means of friction surfaces. To this second cylindrical supporting block, a ring-shaped conductive adjustment plane is connected. A second conductive adjustment plane, in turn, is connected to the adjustment mechanism and arranged in a center hole of the ring-shaped adjustment plane and attached to the second supporting block in a manner which transfers the movement of the adjustment mechanism so that it first moves the second adjustment plane for a predetermined adjustment range, and thereafter both adjustment planes together. Thus, the frequency controller has two slopes of adjustment, whereby the adjustment is fast, owing to the movement of both adjustment planes, and also extremely accurate, owing to the fine adjustment function, which is achieved when the smaller adjustment plane is moved alone.
Patent DE-69520696-D1 (DE)
Inventor: HUANG ZHENG
IPC: H04N21/2383
Filed: 1995-01-14
Granted: 2001-05-23
Abstract: An outer symbol error correcting code is concatenated with a punctured multidimensional trellis code to provide an optimal scheme for communicating digital television signals in a standard (e.g., approximately six MHz) bandwidth channel via a cable television network or the like. An input signal (10) is encoded using an outer symbol error correcting code (12) to produce successive blocks. Each block comprises N seven-bit coded symbols of which M represent information to be communicated and the remaining N-M coded symbols comprise error correcting information. M/N is either 120/126, 121/127 or 122/128. The blocks are interleaved (18), and may be supplemented with control symbols (19) that include a synchronization pattern for M/N = 121/127 or M/N = 122/128. The interleaved blocks are convolutionally encoded using an inner trellis code (20) having a punctured rate 4/5 (sixty-four QAM) or 3/4 (sixteen QAM). The output symbols are multilevel modulated (21) for transmission over a communication path (26) using, for example, sixteen or sixty-four QAM. The transmitted symbols are decoded using a trellis decoder (32), deinterleaved (34), and further decoded in an outer symbol error decoder (36) concatenated with the inner trellis decoder (32). <IMAGE>
Patent DE-69520802-D1 (DE)
Inventor: HEYMAN DUANE A
IPC: C08G18/63
Filed: 1995-01-16
Granted: 2001-06-07
Abstract: There is a provided a stable low viscosity graft polymer dispersion comprising from 25 to 60 weight percent based on the total weight of the polymer dispersion of at least three ethylenically unsaturated monomers polymerized in the presence of a reaction moderator and a free radical initiator in a polyol mixture initially containing less than 0.1 moles of induced unsaturation per mole of said polyol mixture. One of the monomers in the mixture of ethylenically unsaturated monomers is a hydroxylfunctional or aminofunctional C2 - C6 alkyl methacrylate.
Patent DE-69601167-D1 (DE)
Inventor: SLOCUM ALEXANDER
IPC: G01R31/02
Filed: 1996-02-27
Granted: 1999-01-28
Abstract: A kinematic coupling for a test system with a test head which must be docked with a handling device. The coupling is implemented with a plurality of modules attached to the test head. Each module has one kinematic surface and is designed to mate with another kinematic surface on the handling device. Each module includes a motor which can extend or retract the kinematic surface. These modules allow docking of the test head to the handling device with a final motion perpendicular to the handler. They also allow the tilt angle between the test head and the handler to be adjusted to achieve planarization.
Patent DE-69601706-D1 (DE)
Inventor: REVOL MICHEL
IPC: C09D11/10
Filed: 1996-05-03
Granted: 1999-04-15
Abstract: PCT No. PCT/IB96/00479 Sec. 371 Date Jan. 6, 1998 Sec. 102(e) Date Jan. 6, 1998 PCT Filed May 3, 1996 PCT Pub. No. WO96/34923 PCT Pub. Date Nov. 7, 1996A lithographic printing ink contains a lithographic varnish containing an alkali soluble or dispersible binder material which is the reaction product of an acid functional hard resin with a fatty ester oil and/or an alkyd resin.
Patent DE-69616542-D1 (DE)
Inventor: BOIVIN PATRICK
IPC: C12C1/00
Filed: 1996-04-23
Granted: 2001-12-06
Abstract: PCT No. PCT/FR96/00621 Sec. 371 Date Jan. 26, 1998 Sec. 102(e) Date Jan. 26, 1998 PCT Filed Apr. 23, 1996 PCT Pub. No. WO96/34085 PCT Pub. Date Oct. 31, 1996The invention provides micro-organism strains of the Geotrichum candidum family, obtainable by selecting and cloning natural strains of the micro-organism, and which have the following properties: a lipase activity of less than 2.5x10-7 nKat per cell; a substantially complete inhibition of undesirable flora developing during malting; and a lack of mutagenic activity as measured by the Ames test.
Patent DE-69621786-D1 (DE)
Inventor: CHIESI PAOLO
IPC: A61P9/04
Filed: 1996-03-13
Granted: 2002-07-18
Abstract: The use of 5,6-diisobutyroyloxy-2-methylaminotetralin in the preparation of pharmaceutical compositions for the therapy of cardiac disorders, particularly of congestive heart failure.
Patent DE-69628599-D1 (DE)
Inventor: MILLER GARY E
IPC: A61L11/00
Filed: 1996-08-02
Granted: 2003-07-10
Abstract: Disclosed herein is a syringe sterilization and disposal unit which utilizes a micro-processor controlled artificial intelligence for operation of the necessary functions to render a used syringe safe for disposal. The syringe sterilization unit includes an "opto-sensor" for signaling the positioning of the syringe for further clamping and processing operations. The lure of a syringe to be processed is exposed to heat from the heat heads to effect separation of the needle. The needle tip gripper jaw heads extract the syringe needle from the syringe body. The heat heads are further used to compress the lure of the syringe body to seal the syringe cavity. The extracted needle is then heated by a needle tip contactor for sterilization whereupon the needle and the sealed syringe cavity are then positioned into an appropriate bin for disposal and/or recycling.
Patent DE-69629591-D1 (DE)
Inventor: ALFONSO MARK
IPC: A61K9/00
Filed: 1996-11-14
Granted: 2003-09-25
Abstract: A dosage form for intranasal and/or inhalation administration of an analgesic having low opioid receptor binding activity to a warm blooded animal, that includes a pharmaceutically effective amount of the analgesic. A preferred analgesic is tramadol, a tramadol and/or a pharmaceutically acceptable salt, metabolite or derivative thereof. Methods of making and using the formulation according to the invention are also provided.
Patent DE-69633196-D1 (DE)
Inventor: OKU TERUO
IPC: C07D239/94
Filed: 1996-10-15
Granted: 2004-09-23
Abstract: PCT No. PCT/JP96/02981 Sec. 371 Date Apr. 14, 1998 Sec. 102(e) Date Apr. 14, 1998 PCT Filed Oct. 15, 1996 PCT Pub. No. WO97/14681 PCT Pub. Date Apr. 24, 1996This invention relates to a quinoline compound of the formula: wherein R1 is a pyridyl group or aryl, each of which may be substituted with suitable substituent(s), A is -COHN- or -NHCO-, n is an integer of 0 or 1, and is a group of the formula: In which R2, R3, R4, R5, R6 and R7 are as defined, and pharmaceutically acceptable salt thereof, to processes for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for the prevention and/or the treatment of bone diseases caused by abnormal bone metabolism in human being or animals.
Patent DE-69635525-D1 (DE)
Inventor: BELLAMINE AOUATEF
IPC: C12Q1/26
Filed: 1996-09-13
Granted: 2006-01-05
Abstract: PCT No. PCT/FR96/01413 Sec. 371 Date May 4, 1998 Sec. 102(e) Date May 4, 1998 PCT Filed Sep. 13, 1996 PCT Pub. No. WO97/10344 PCT Pub. Date Mar. 20, 1997Yeast strains expressing human genes coding regulating cytochrome P450 expression, a method for making same and applications thereof are described.
Patent DE-69702748-D1 (DE)
Inventor: VAN DEN BERG JAN
IPC: C07D493/08
Filed: 1997-02-21
Granted: 2000-09-14
Abstract: The invention pertains to a coating composition comprising a first compound comprising at least one bicyclo- or spiro-orthoester group and as a second compound an amino resin. The invention also comprises a process for curing the present coating composition. More particularly, the latent hydroxyl groups of the bicyclo- or spiro-orthoester groups have to be deblocked and reacted with the hydroxyl-reactive groups of the amino resin if the present coating composition is to be cured.
Patent DE-69704628-D1 (DE)
Inventor: FOWLER MICHAEL
IPC: C09D175/04
Filed: 1997-09-24
Granted: 2001-05-23
Abstract: In a process for overcoating a substrate having a cured primer coating with a curable topcoat which when cured is swellable by a stripping solvent, a non-volatile polar material is applied to the primed substrate from an aqueous liquid vehicle before coating with the topcoat. The polar material facilitates the removal of the topcoat from the primer by the stripping solvent, as is required for example when repainting aircraft. The polar material has sufficiently high affinity for the primer surface that it is not washed off the primer surface by water rinsing or by application of the topcoat paint.